Need professional-grade analysis? Visit stockanalysis.com
$10.35M
N/A
N/A
N/A
Quoin Pharmaceuticals Ltd DRC (QNRX) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $5.73, down 0.17% from the previous close.
Over the past year, QNRX has traded between a low of $5.73 and a high of $22.30. The stock has lost 13.2% over this period. It is currently 74.3% below its 52-week high.
Quoin Pharmaceuticals Ltd DRC has a market capitalization of $10.35M.
Quoin Pharmaceuticals, Ltd., a late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). It also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat Netherton Syndrome; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.
Side-by-side comparison against top Healthcare peers.